Cerner Corp. has signed an agreement to acquire Kantar Health, a division of Kantar Group, for $375 million in cash, subject to adjustment.
Kantar Health is a data, analytics and real-world evidence and commercial research consultancy serving the life science industry. This acquisition is expected to allow Cerner’s Learning Health Network client consortium to more directly engage with life sciences for funded research studies.
The Learning Health Network was rolled out to more effectively treat global diseases through an acceleration of clinical research, said Cerner President Donald Trigg.
“Kantar Health has incredible health economics and medical affairs expertise, differentiated real-world data assets and strong relationships with the world’s leading life science companies,” he said. “It offers us an amazing opportunity to drive cross-industry collaboration that can change health outcomes around the world.”
The Cerner Learning Health Network offers health systems free access to a network of bi-directional, de-identified data resources. This access helps advance research efforts and provides opportunities to generate revenue with funded research studies from life science companies.
“At Kantar Health we’re proud of our heritage and reputation as consultants to the world’s leading life sciences manufacturers,” said Kantar Health CEO Lynnette Cooke. “We are excited about this next chapter, where our real-world evidence and commercial data assets will be powered by Cerner.”